DIADIA0.18%
SPYSPY0.27%
QQQQQQ0.68%
Trending
Top trending tickerKOKO0.22%
DPZDPZ6.46%
SLSSLS1.44%
FOXAFOXA0.04%
PENGUPENGU1.18%
UPSTUPST0.75%
UMCUMC5.08%
EBAYEBAY0.79%
OXYOXY0.09%
RKLBRKLB3.31%
Top trending tickerKOKO0.22%
DPZDPZ6.46%
SLSSLS1.44%
FOXAFOXA0.04%
PENGUPENGU1.18%
UPSTUPST0.75%
UMCUMC5.08%
EBAYEBAY0.79%
OXYOXY0.09%
RKLBRKLB3.31%

Feed

News

Sentiment

Earnings

Fundamentals

Info

homeSymbolGENBnews
Exchange: NASDAQ·Updated 04:02 AM EDT
GENB logo

GENBGenerate Biomedicines Inc

$13.63
$0.07
(0.52%)
Pre-Market
Prev Close $13.56
EarningsAug 6
Mkt Cap$1.74B
Vol315.00
News
all
press releases
Nvidia CEO Jensen Huang Said AI's 'Most Profound Impact Will Be in Life Sciences.' Does This Bet on a Biotech Stock Prove He Means It?
Key PointsThe chipmaker has active interests in the healthcare market, including a partnership with Eli Lilly and an investment in small biotech Generate Biomedicines...
Nasdaq News: Markets
News Placeholder
More News
News Placeholder
Cathie Wood Likes That New Stock Smell: 3 IPO Stocks She Bought on Monday
Key PointsCathie Wood added to her positions in Space Exploration, Bullish, and Generate Biomedicines on Monday...
Nasdaq News: Markets
News Placeholder
AdvanCell Signs 128,000 Square Foot, Full Building Lease at IQHQ's Innovation Park in Andover, Massachusetts
AdvanCell Signs 128,000 Square Foot, Full Building Lease at IQHQ's Innovation Park in Andover, Massachusetts AdvanCell Signs 128,000 Square Foot, Full Building Lease at IQHQ's Innovation Park in Andover, Massachusetts PR Newswire BOSTON, June 22, 2026 Newly Constructed Phase 2 now 100...
PR Newswire
News Placeholder
A New $21 Million Position Signals Confidence in This Post-IPO Drug Developer
Key PointsHarbourVest initiated 1,722,210 shares of Generate Biomedicines last quarter; the estimated trade size was $21.03 million based on quarterly average prices...
Nasdaq News: Markets
News Placeholder
Generate Biomedicines Inc. to Participate in Goldman Sachs 47th Annual Global Healthcare Conference
Generate Biomedicines Inc. to Participate in Goldman Sachs 47th Annual Global Healthcare Conference Generate Biomedicines Inc. to Participate in Goldman Sachs 47th Annual Global Healthcare Conference PR Newswire SOMERVILLE, Mass., May 28, 2026 SOMERVILLE, Mass., May 28, 2026 /PRNewswire...
PR Newswire
News Placeholder
Generate Biomedicines, Inc. Reports First Quarter 2026 Financial Results and Provides Business Update
Generate Biomedicines, Inc. Reports First Quarter 2026 Financial Results and Provides Business Update Generate Biomedicines, Inc. Reports First Quarter 2026 Financial Results and Provides Business Update PR Newswire SOMERVILLE, Mass., May 7, 2026 SOLAIRIA-1 AND SOLAIRIA-2 Phase 3 clinical trials...
PR Newswire
News Placeholder
Generate Biomedicines (NASDAQ:GENB) Hits New 1-Year High - Should You Buy?
Generate Biomedicines (NASDAQ:GENB) Reaches New 52-Week High - Time to Buy...
MarketBeat
News Placeholder
Generate Biomedicines (NASDAQ:GENB) Trading Up 8.1% - Should You Buy?
Generate Biomedicines (NASDAQ:GENB) Shares Up 8.1% - Still a Buy...
MarketBeat
News Placeholder
Generate Biomedicines Inc (NASDAQ:GENB) Given Consensus Rating of "Moderate Buy" by Analysts
Generate Biomedicines Inc (NASDAQ:GENB - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the seven analysts that are covering the stock, Marketbeat Ratings...
MarketBeat
News Placeholder
Research Analysts Set Expectations for GENB Q1 Earnings
Generate Biomedicines Inc (NASDAQ:GENB - Free Report) - Stock analysts at HC Wainwright issued their Q1 2026 earnings estimates for Generate Biomedicines in a report issued on Monday, April 13th. HC...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.

Advertisement|Remove ads.